75
Participants
Start Date
September 21, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Amikacin
patient will be treated with amikacin 15 mg/kg IV or IM, based on actual body weight; for patients \>120% of IBW, we will use AdjBW (IBW + 0.4(ABW-IBW)) rounded to nearest 50 mg. Patients who already have an IV will receive the medication IV, otherwise the dose will be given IM.
RECRUITING
Maimonides Medical Center, Brooklyn
Antonios Likourezos
OTHER